Bandhan BSE Healthcare Index Fund Regular-Growth

Fund Details

NAV 9.4135

Sub-Type Sectoral-Pharma

Rating Not Rated

Min. SIP Amount ₹100.0

Fund Age(Year) 1.54

Fund Size(in Crores) 16.75

Fund Performance

1 Month -4.89%

3 Month -6.57%

6 Month -7.65%

1 Year -2.44%

3 Year 0.0%

5 Year 0.0%

Know This Fund

As on 24 Mar 2026

Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.

Equity (100.07%) Market Cap Mid Cap 33.04 Small Cap 22.84 Large Cap 44.19 Top Sectors Healthcare 99.57 Services 0.3 Chemicals 0.2 Top Holding Sigachi Industries 0.03 Pfizer 0.56 Lincoln Pharma 0.04 KMC Speciality Hospitals (India) 0.02 Natco Pharma 0.65 Sastasundar Ventures 0.02 Windlas Biotech 0.04 Unichem Laboratories 0.05 Cohance Lifesciences 0.36 SMS Pharmaceuticals 0.08 Metropolis Healthcare 0.36 Anuh Pharma 0.02 Gufic Biosciences 0.06 Aarti Pharmalabs 0.28 Sai Life Sciences 1 Jubilant Pharmova 0.51 Glaxosmithkline Pharma 0.77 Shalby 0.03 Thyrocare Technologies 0.13 Ajanta Pharma 0.93 Krsnaa Diagnostics 0.08 Syncom Formulations (India) 0.04 Alkem Laboratories 2.43 Strides Pharma Science 0.42 Fermenta Biotech 0.02 Artemis Medicare Services 0.05 Senores Pharmaceuticals 0.15 Shree Ganesh Remedies 0.01 Concord Biotech 0.3 Novartis India 0.04 Morepen Laboratories 0.11 Indoco Remedies 0.05 Alivus Life Sciences 0.21 Kovai Medical Center & Hospital 0.18 Torrent Pharmaceuticals 3.35 Onesource Specialty Pharma 0.53 Bliss GVS Pharma 0.1 3B BlackBio Dx 0.05 Innova Captab 0.08 Narayana Hrudayalaya 0.91 Apollo Hospitals Enterprise 5.87 Nectar Lifesciences 0.01 Mankind Pharma 1.84 Hester Biosciences 0.04 Aurobindo Pharma 2.5 Healthcare Global Enterprises 0.21 Poly Medicure 0.36 Aster DM Healthcare 1.12 Biocon 2.04 Astrazeneca Pharma India 0.41 Sun Pharmaceutical Industries 13.49 Tarsons Products 0.02 Laxmi Dental 0.03 Jupiter Life Line Hospitals 0.35 Lupin 4.1 Rainbow Children's 0.43 Emcure Pharmaceuticals 0.32 Zydus Lifesciences 1.71 Solara Active Pharma Sciences 0.1 Orchid Pharma 0.07 Advanced Enzyme Technologies 0.11 Sanofi India 0.26 Sanofi Consumer Healthcare India 0.22 Wockhardt 0.83 Max Healthcare Institute 5.93 Vijaya Diagnostic Centre 0.36 FDC 0.13 Caplin Point Laboratories 0.25 Blue Jet Healthcare 0.11 Jagsonpal Pharmaceuticals 0.02 Sun Pharma Adv Resrc 0.09 Aarti Drugs 0.1 Abbott India 1.03 Akums Drugs And Pharmaceuticals 0.1 Gland Pharma 1.06 Panacea Biotec 0.04 Dr. Agarwal's Health Care 0.46 Themis Medicare 0.02 Procter & Gamble Health 0.29 Glenmark Pharmaceuticals 2.35 Dr. Reddy's Laboratories 5.77 Suven Life Sciences 0.07 Supriya Lifescience 0.12 Marksans Pharma 0.27 Kwality Pharmaceuticals 0.05 Dishman Carbogen Amcis 0.08 Fischer Medical Ventures 0.04 IOL Chemicals 0.06 Divi's Laboratories 6.01 Alembic Pharmaceuticals 0.29 Suraksha Diagnostic 0.04 Viyash Scientific 0.19 Bajaj Healthcare 0.03 Fortis Healthcare 3.61 Kopran 0.03 Cipla 5.6 RPG Life Sciences 0.06 GPT Healthcare 0.03 JB Chemicals 1.23 Indraprastha Medical Corporation 0.13 Eris Lifesciences 0.41 Laurus Labs 3.07 Piramal Pharma 0.7 Syngene International 0.59 Krishna Institute 1.36 Dr Agarwals Eye Hospital 0.04 Acutaas Chemicals 0.82 Dr. Lal Pathlabs 0.79 Yatharth Hospital & Trauma Care Services 0.19 Indegene 0.38 Hikal 0.05 Ipca Laboratories 1.57 Granules India 0.62 Global Health 0.7 Shilpa Medicare 0.27 Wanbury 0.04 Neuland Laboratories 0.81 Gujarat Themis 0.07 Vimta Labs 0.05

Debt & Others (-0.07%) Sector Allocation Net Payables -0.31 Reverse Repo 0.24 Margin Money 0 Debt Credit Ratings Debt Category Others -0.07

Comparison with same funds

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -4.89% Ret 1Y -2.44% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -5.25% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Charges & Taxes Expense Ratio

Returns are taxed as per your Income Tax Slab.

Expense Ratio (Inclusive of GST): 1.03%

Exit Load 0.25%

Stamp Duty 0.005%

Fund Management

The various expenses, charges and taxes associated with your Mutual Fund

Abhishek Jain

Education Mr. Jain has done BA, CA

Experience Prior to joining Bandhan MF he was associated with Groww MF, Edelweiss Tokio Life Insurance, Acko General Insurance and Shriram Asset Management Co Ltd.

Nemish Sheth

Education Mr. Sheth is a B.Com, PGDM(FINANCE)

Experience Prior to joining Nippon Mutual Fund, he has worked with Bandhan MF, Nippon Life India Asset Management Ltd. and ICICI Prudential Asset Management Company Ltd.

Mayuresh Nagvekar

Education B.Com in Financial Management

Experience Prior to joining the Bandhan AMC, he was associated with Colour Arts,

Riskometer

Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.

Principal at very high risk

AMC and Fund details

Rank (total sets) 17

Date of Incorporation 2024-09-06

Total AUM 197898.6

The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.